Snowden Capital Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,507
Closed -$207K 1252
2025
Q2
$207K Sell
3,507
-4,607
-57% -$298K 0.01% 1160
2025
Q1
$594K Buy
+8,114
New +$670K 0.02% 667

Other funds holding GMED

Snowden Capital Advisors's GMED Position: Q3 2025 in Review

Snowden Capital Advisors sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 3,507 shares — an estimated $207K sold.

Snowden Capital Advisors first reported a position in GMED in Q1 2025 and held it in 2 quarters. The position peaked at $594K in Q1 2025. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

  • Snowden Capital Advisors reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
  • Snowden Capital Advisors sold 3,507 Globus Medical shares in Q3 2025, an estimated $207K.
  • Snowden Capital Advisors first reported a position in Globus Medical in Q1 2025 and held it in 2 quarters.
  • Snowden Capital Advisors's Globus Medical position peaked at $594K in Q1 2025.
  • 489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Snowden Capital Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.